Table of Contents

Executive Summary

1 Industry Overview of Gleevec

• 1.1 Definition of Gleevec
• 1.2 Gleevec Segment by Type
  • 1.2.1 Global Gleevec Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 100mg
  • 1.2.3 400mg
• 1.3 Gleevec Segment by Applications
  • 1.3.1 Global Gleevec Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Pharmacy
• 1.4 Global Gleevec Overall Market
  • 1.4.1 Global Gleevec Revenue (2014-2025)
  • 1.4.2 Global Gleevec Production (2014-2025)
  • 1.4.3 North America Gleevec Status and Prospect (2014-2025)
  • 1.4.4 Europe Gleevec Status and Prospect (2014-2025)
  • 1.4.5 China Gleevec Status and Prospect (2014-2025)
  • 1.4.6 Japan Gleevec Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Gleevec Status and Prospect (2014-2025)
  • 1.4.8 India Gleevec Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Gleevec
• 2.3 Manufacturing Process Analysis of Gleevec
• 2.4 Industry Chain Structure of Gleevec

3 Development and Manufacturing Plants Analysis of Gleevec

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Gleevec Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Gleevec
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Gleevec Production and Capacity Analysis
• 4.2 Gleevec Revenue Analysis
• 4.3 Gleevec Price Analysis
• 4.4 Market Concentration Degree

5 Gleevec Regional Market Analysis

• 5.1 Gleevec Production by Regions
  • 5.1.1 Global Gleevec Production by Regions
  • 5.1.2 Global Gleevec Revenue by Regions
• 5.2 Gleevec Consumption by Regions
• 5.3 North America Gleevec Market Analysis
  • 5.3.1 North America Gleevec Production
  • 5.3.2 North America Gleevec Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Gleevec Import and Export
• 5.4 Europe Gleevec Market Analysis
  • 5.4.1 Europe Gleevec Production
  • 5.4.2 Europe Gleevec Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Gleevec Import and Export
• 5.5 China Gleevec Market Analysis
  • 5.5.1 China Gleevec Production
  • 5.5.2 China Gleevec Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Gleevec Import and Export
• 5.6 Japan Gleevec Market Analysis
  • 5.6.1 Japan Gleevec Production
  • 5.6.2 Japan Gleevec Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Gleevec Import and Export
• 5.7 Southeast Asia Gleevec Market Analysis
  • 5.7.1 Southeast Asia Gleevec Production
  • 5.7.2 Southeast Asia Gleevec Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Gleevec Import and Export
• 5.8 India Gleevec Market Analysis
  • 5.8.1 India Gleevec Production
  • 5.8.2 India Gleevec Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Gleevec Import and Export

6 Gleevec Segment Market Analysis (by Type)

• 6.1 Global Gleevec Production by Type
• 6.2 Global Gleevec Revenue by Type
• 6.3 Gleevec Price by Type

7 Gleevec Segment Market Analysis (by Application)

• 7.1 Global Gleevec Consumption by Application
• 7.2 Global Gleevec Consumption Market Share by Application (2014-2019)

8 Gleevec Major Manufacturers Analysis

• 8.1 Novartis
  • 8.1.1 Novartis Gleevec Production Sites and Area Served
  • 8.1.2 Novartis Product Introduction, Application and Specification
  • 8.1.3 Novartis Gleevec Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served

9 Development Trend of Analysis of Gleevec Market

• 9.1 Global Gleevec Market Trend Analysis
  • 9.1.1 Global Gleevec Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Gleevec Regional Market Trend
  • 9.2.1 North America Gleevec Forecast 2019-2025
  • 9.2.2 Europe Gleevec Forecast 2019-2025
  • 9.2.3 China Gleevec Forecast 2019-2025
  • 9.2.4 Japan Gleevec Forecast 2019-2025
  • 9.2.5 Southeast Asia Gleevec Forecast 2019-2025
  • 9.2.6 India Gleevec Forecast 2019-2025
• 9.3 Gleevec Market Trend (Product Type)
• 9.4 Gleevec Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Gleevec Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Imatinib is a medication used to treat cancer.

The global Gleevec market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Gleevec volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gleevec market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gleevec in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gleevec manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
100mg
400mg

Segment by Application
Hospital
Pharmacy